norfloxacin has been researched along with cephalosporin c in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (29.41) | 18.7374 |
| 1990's | 14 (41.18) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Hoshino, K; Saiki, A; Sawai, T; Yamaguchi, A | 1 |
| Bischoff, W; Hyslop, DL | 1 |
| Bischoff, W; Iravani, A | 1 |
| Saran, A; Soback, S; Winkler, M; Ziv, G | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Daikos, GL; Jackson, GG; Lolans, VT | 1 |
| Butzler, JP; Coignau, H; De Mol, P; Ghysels, G; Goossens, H; Grados, O; Innocent, H; Levy, J | 1 |
| Appelbaum, PC; Sollenberger, L; Spangler, SK | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Cheong, YM; Joseph, PG; Koay, AS | 1 |
| Hanno, P | 1 |
| Neu, HC | 1 |
| Bryskier, A; Croize, J; Le Noc, P; Robert, J | 1 |
| Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
| Mortimer, PG; Piddock, LJ | 1 |
| Inoue, M; Kobayashi, I; Takahashi, A; Ushijima, Y; Yomoda, S | 1 |
| Gallés, C; Gasós, MA; Sauca, G | 1 |
| Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
| Baquero, F; Cisterna, R; García-Rodríguez, JA; Gobernado, M; Liñares, F; Martín-Luengo, F; Piédrola, G; Trujillano Martín, I | 1 |
| Kinoshita, S; Kumagai, S | 1 |
| Balanzó, J; Guarner, C; Kolle, L; Novella, MT; Ortiz, J; Pamplona, J; Sàbat, M; Sainz, S; Soriano, G; Torras, J; Villanueva, C | 1 |
| Caron, F | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Chevalier, J; Malléa, M; Pagès, JM | 1 |
| Eampokalap, B; Moolasart, P; Ratanasrithong, M | 1 |
| Banke, S; Bergman, B; Boman, H; Cronberg, S; Eilard, T; Elbel, E; Hugo-Persson, M; Johansson, E; Kuylenstierna, N; Lanbeck, P; Lindblom, A; Paulsen, O; Schönbeck, C; Walder, M; Wieslander, P | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
| Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M | 1 |
| Cao, Y; Ding, Z; Gong, Y; Jiang, H; Liu, X; Song, X; Wang, F; Wang, T; Wang, W; Zhang, N; Zhang, W; Zhang, Z | 1 |
| Cattrall, JWS; Kirby, A; Robinson, AV | 1 |
7 review(s) available for norfloxacin and cephalosporin c
| Article | Year |
|---|---|
Antibiotic therapy for urinary tract infections.
Topics: Cefaclor; Cephalosporins; Clinical Trials as Topic; Europe; Female; Humans; Male; Norfloxacin; United States; Urinary Tract Infections | 1992 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
Therapeutic principles of antimicrobial therapy and new antimicrobial agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Humans; Monobactams; Norfloxacin; Penicillin Resistance; Penicillins; Thienamycins; Urinary Tract Infections | 1986 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim | 2018 |
4 trial(s) available for norfloxacin and cephalosporin c
| Article | Year |
|---|---|
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cephalosporins; Diarrhea; Double-Blind Method; Europe; Female; Headache; Humans; Male; Middle Aged; Nausea; Norfloxacin; Pyelonephritis; Treatment Outcome; United States | 1992 |
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Cost-Benefit Analysis; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Norfloxacin | 1998 |
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
Topics: Acute Disease; Anti-Infective Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Diarrhea; Drug Resistance, Microbial; Dysentery, Bacillary; Female; Humans; Infant; Male; Norfloxacin; Prospective Studies; Salmonella Infections | 1999 |
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Norfloxacin; Prospective Studies; Pyelonephritis; Recurrence; Treatment Outcome | 2001 |
23 other study(ies) available for norfloxacin and cephalosporin c
| Article | Year |
|---|---|
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
OmpF channel permeability of quinolones and their comparison with beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Cell Membrane Permeability; Cephalosporins; Diffusion; Enoxacin; Escherichia coli; Liposomes; Nalidixic Acid; Norfloxacin; Ofloxacin; Stereoisomerism | 1992 |
Systemic dry cow therapy--a preliminary report.
Topics: Animals; Cattle; Cephalosporins; Cephapirin; Female; Injections, Intramuscular; Injections, Subcutaneous; Mastitis, Bovine; Microbial Sensitivity Tests; Norfloxacin; Oxytetracycline; Random Allocation; Staphylococcal Infections; Staphylococcus aureus | 1990 |
Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cell Membrane; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Norfloxacin; Penicillins; Pseudomonas aeruginosa | 1988 |
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Topics: Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Leucomycins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
Topics: Anti-Infective Agents; Cefpirome; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines | 1986 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
In-vitro susceptibility of Pseudomonas pseudomallei isolated in Malaysia to some new cephalosporins and a quinolone.
Topics: Cephalosporins; Melioidosis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas | 1987 |
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Topics: Acinetobacter; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas aeruginosa | 1985 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli.
Topics: Anti-Infective Agents; Cefoxitin; Cephalosporins; Chloramphenicol; Escherichia coli; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Porins; Tetracycline | 1993 |
Ofloxacin, norfloxacin and ceftazidime increase the production of alginate and promote the formation of biofilm of Pseudomonas aeruginosa in vitro.
Topics: Alginates; Anti-Infective Agents; Biofilms; Ceftazidime; Cephalosporins; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa | 1995 |
[Changes in the sensitivity of Escherichia coli to 6 antimicrobial agents during the last 12 years. Group of Microbiologists of County Hospitals of Catalonia].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Spain; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus | 1997 |
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Excipients; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Norfloxacin; Spain; Tromethamine; Urinary Tract Infections | 1997 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae.
Topics: Binding, Competitive; Biological Transport; Cefepime; Cephalosporins; Drug Interactions; Enterobacter cloacae; Microbial Sensitivity Tests; Norfloxacin; Porins; Spermine | 2000 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins | 2011 |
Efficacy of cefepime, ertapenem and norfloxacin against leptospirosis and for the clearance of pathogens in a hamster model.
Topics: Animal Structures; Animals; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cricetinae; Disease Models, Animal; Ertapenem; Histocytochemistry; Leptospira interrogans serovar autumnalis; Leptospirosis; Norfloxacin; Survival Analysis; Treatment Outcome | 2014 |